6-heptyne-2,5-diamine has been researched along with Lupus Erythematosus, Systemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Claverie, N; Danzin, C; Mamont, PS; Pasquali, JL; Siat, M; Weil-Bousson, M | 1 |
1 other study(ies) available for 6-heptyne-2,5-diamine and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice.
Topics: Alkynes; Animals; Autoantibodies; Diamines; Female; Immunoglobulin G; Immunoglobulin M; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lymphatic Diseases; Mice; Mice, Inbred Strains; Ornithine Decarboxylase Inhibitors; S-Adenosylmethionine; Splenomegaly; Time Factors | 1988 |